These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15955628)

  • 1. Gastrin-releasing peptide induces c-Fos in the hamster suprachiasmatic nucleus.
    Piggins HD; Goguen D; Rusak B
    Neurosci Lett; 2005 Aug; 384(3):205-10. PubMed ID: 15955628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of photic shifts with the 5-HT1A mixed agonist/antagonist NAN-190: intra-suprachiasmatic nucleus pathway.
    Sterniczuk R; Stepkowski A; Jones M; Antle MC
    Neuroscience; 2008 May; 153(3):571-80. PubMed ID: 18406538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific effects of gastrin-releasing peptide in the suprachiasmatic nucleus.
    Kallingal GJ; Mintz EM
    Eur J Neurosci; 2014 Feb; 39(4):630-9. PubMed ID: 24528136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dark pulse suppression of P-ERK and c-Fos in the hamster suprachiasmatic nuclei.
    Coogan AN; Piggins HD
    Eur J Neurosci; 2005 Jul; 22(1):158-68. PubMed ID: 16029205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABAergic regulation of light-induced c-Fos immunoreactivity within the suprachiasmatic nucleus.
    Gillespie CF; Van Der Beek EM; Mintz EM; Mickley NC; Jasnow AM; Huhman KL; Albers HE
    J Comp Neurol; 1999 Sep; 411(4):683-92. PubMed ID: 10421877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the role of substance P in photic responses of the circadian system: individual and combined actions with gastrin-releasing peptide.
    Sterniczuk R; Colijn MA; Nunez M; Antle MC
    Neuropharmacology; 2010 Jan; 58(1):277-85. PubMed ID: 19540856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamatergic activity modulates the phase-shifting effects of gastrin-releasing peptide and light.
    Kallingal GJ; Mintz EM
    Eur J Neurosci; 2006 Nov; 24(10):2853-8. PubMed ID: 17156209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrin-releasing peptide phase-shifts suprachiasmatic nuclei neuronal rhythms in vitro.
    McArthur AJ; Coogan AN; Ajpru S; Sugden D; Biello SM; Piggins HD
    J Neurosci; 2000 Jul; 20(14):5496-502. PubMed ID: 10884333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian regulation of c-fos expression in the suprachiasmatic pacemaker by light.
    Earnest DJ; Olschowka JA
    J Biol Rhythms; 1993; 8 Suppl():S65-71. PubMed ID: 8274764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An NMDA antagonist inhibits light but not GRP-induced phase shifts when administered after the phase-shifting stimulus.
    Kallingal GJ; Mintz EM
    Brain Res; 2010 Sep; 1353():106-12. PubMed ID: 20682305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrin-releasing peptide mediates light-like resetting of the suprachiasmatic nucleus circadian pacemaker through cAMP response element-binding protein and Per1 activation.
    Gamble KL; Allen GC; Zhou T; McMahon DG
    J Neurosci; 2007 Oct; 27(44):12078-87. PubMed ID: 17978049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of photic stimuli disturbing overt circadian rhythms on the dorsomedial and ventrolateral SCN rhythmicity.
    Sumová A; Illnerová H
    Brain Res; 2005 Jun; 1048(1-2):161-9. PubMed ID: 15913573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The opioid fentanyl affects light input, electrical activity and Per gene expression in the hamster suprachiasmatic nuclei.
    Vansteensel MJ; Magnone MC; van Oosterhout F; Baeriswyl S; Albrecht U; Albus H; Dahan A; Meijer JH
    Eur J Neurosci; 2005 Jun; 21(11):2958-66. PubMed ID: 15978007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light-induced c-Fos expression in suprachiasmatic nuclei neurons targeting the paraventricular nucleus of the hamster hypothalamus: phase dependence and immunochemical identification.
    Munch IC; Møller M; Larsen PJ; Vrang N
    J Comp Neurol; 2002 Jan; 442(1):48-62. PubMed ID: 11754366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of 5-HT2C receptors acutely induces Per1 gene expression in the rat SCN in vitro.
    Varcoe TJ; Kennaway DJ
    Brain Res; 2008 May; 1209():19-28. PubMed ID: 18400210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Fos expression necessary and sufficient to mediate light-induced phase advances of the suprachiasmatic circadian oscillator?
    Rea MA; Michel AM; Lutton LM
    J Biol Rhythms; 1993; 8 Suppl():S59-64. PubMed ID: 8274763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily and circadian expression of neuropeptides in the suprachiasmatic nuclei of nocturnal and diurnal rodents.
    Dardente H; Menet JS; Challet E; Tournier BB; Pévet P; Masson-Pévet M
    Brain Res Mol Brain Res; 2004 May; 124(2):143-51. PubMed ID: 15135222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin1A autoreceptor activation by S 15535 enhances circadian activity rhythms in hamsters: evaluation of potential interactions with serotonin2A and serotonin2C receptors.
    Gannon RL; Millan MJ
    Neuroscience; 2006; 137(1):287-99. PubMed ID: 16289351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin-releasing peptide mediates photic entrainable signals to dorsal subsets of suprachiasmatic nucleus via induction of Period gene in mice.
    Aida R; Moriya T; Araki M; Akiyama M; Wada K; Wada E; Shibata S
    Mol Pharmacol; 2002 Jan; 61(1):26-34. PubMed ID: 11752203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomical and functional characterisation of a dopaminergic system in the suprachiasmatic nucleus of the neonatal Siberian hamster.
    Duffield GE; McNulty S; Ebling FJ
    J Comp Neurol; 1999 May; 408(1):73-96. PubMed ID: 10331581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.